Delivery Order SPE2DB24D1021-SPE2DB25FEVYE

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules. The contract has a firm fixed price of $13,261.27 and an ultimate completion date of August 5, 2024. It is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,466.57, is a delivery order with a firm fixed price for the supply of 4567796101 - FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has an ultimate completion date of April 4, 2025. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,282.44 for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of April 4, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $26,089.45, is a delivery order for the procurement of Fingolimod 0.5mg 30s, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2023 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,485.98, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication, with a completion date of November 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,817.40 firm-fixed-price contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fingolimod 0.5 mg capsules, a medication used for the treatment of multiple sclerosis. The contract has a ceiling value of $5,916.96 and a period of performance through April 14, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564377288 units of Fingolimod 0.5 mg capsules. The contract, valued at $33,275.45, was awarded on April 23, 2024 by the Defense Logistics Agency Troop Support Medical, with a completion date of April 24, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $30,035.71, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of October 29, 2024 and uses a Firm Fixed Price pricing type. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $5,489.88 and has a performance period through January 27, 2025. It is for the procurement of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEVYE
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,317.23, is for the delivery of Fingolimod 0.5 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract award is likely a task order or delivery order under that larger IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not designated as a set-aside.

Generated 7/15/25, 4:08 PM